Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors-Reference-Cited by-同舟云学术

Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors

Published:2023-01 Issue: Volume:130 Page:106211
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wang Yu,Liu Yajing,Ge Tingjie,Tang Jiechun,Wang Shihui,Gao Zhanfeng,Chen Jiaxu,Xu Jundong,Gong Ping,Zhao Yanfang,Liu Jiuyu,Hou Yunlei^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference50 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin,2022

2. Efficacy of PI3K inhibitors in advanced breast cancer;Verret;Ann. Oncol.,2019

3. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism;Engelman;Nat. Rev. Genet.,2006

4. The phosphoinositide 3-kinase pathway;Cantley;Science,2002

5. The phosphatidylinositol 3-Kinase AKT pathway in human cancer;Vivanco;Nat. Rev. Cancer,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzimidazole‐Containing Compounds as Anticancer Agents;ChemistrySelect;2024-08-22

2. Visible Light-Induced Radical Cascade Difluoromethylation/Cyclization of Unactivated Alkenes: Access to CF₂H-Substituted Polycyclic Imidazoles;ACS Omega;2024-06-19

3. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition;European Journal of Medicinal Chemistry;2024-05

4. Structure-based drug design, synthesis, and biological evaluation of novel 1,3,5-triazine or pyrimidine derivatives containing benzoyl hydrazine moiety as PI3Kα selective inhibitors;Bioorganic Chemistry;2023-11

5. Design, synthesis and antitumor effects of novel benzimidazole derivatives as PI3K inhibitors;Bioorganic & Medicinal Chemistry Letters;2023-10